Patent Yard Sign in
European application, no grantEurope

32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor

EP 1268809 A2 · Applicant: Millennium Pharmaceuticals, Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed March 23, 2001 and never granted as a European patent. Had it been granted, its 20-year term would have ended March 23, 2021.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 23, 2026.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 23, 2001
PublishedJanuary 2, 2003
GrantedNever granted
Term endedMarch 23, 2021
Application numberEP 01920767
Classification (CPC)C12N9/0004

Timeline

Timeline From EPO dates

2002200420062008201020122014201620182020Application filedMarch 23, 2001PublishedJan 2, 2003Term endedMarch 23, 2021

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.